Inventor · disambiguated record
Anders M. Naar
Also filed as: NAAR ANDERS M · NAAR ANDERS MICHAEL · NÄÄR ANDERS
12 granted patents·8 pending applications·15 citations·filing 2010–2023
86Inventor score
Files withMASSACHUSETTS GEN HOSPITAL12NAAR ANDERS M4DANA FARBER CANCER INST INC1GEN HOSPITAL CORP1THE GENERA HOSPITAL CORP1
Top patents by PatentIndex Score
20 records- 0182US10626395B2Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophyMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Apr 21, 2020·1 cites·24 claims
- 0280US9476046B2Methods targeting miR-128 for regulating cholesterol/lipid metabolismMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Oct 25, 2016·4 cites·17 claims
- 0379US12152241B2Targeting human satellite II (HSATII)MASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Nov 26, 2024·1 cites·17 claims
- 0479US8557746B2High throughput screens for small-molecule inhibitors of the nuclear receptor-like pathway regulating multidrug resistance in fungiNAAR ANDERS M·Filed 2010·Granted Oct 15, 2013·5 cites·4 claims
- 0572US2022213477A1Therapeutic Targeting of a microRNA to Treat Duchenne Muscular DystrophyMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 0671US9789132B2Methods targeting miR-128 for regulating cholesterol/lipid metabolismMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Oct 17, 2017·1 cites·15 claims
- 0770US10301624B2Targeting human satellite II (HSATII)MASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted May 28, 2019·1 cites·25 claims
- 0869US12121534B2Agents and methods for treating pancreatic ductal adenocarcinomasMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Oct 22, 2024·0 cites·5 claims
- 0969US9045749B2Methods targeting miR-128 for regulating cholesterol/lipid metabolismNAAR ANDERS M·Filed 2012·Granted Jun 2, 2015·2 cites·20 claims
- 1067US11236336B2Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophyMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Feb 1, 2022·0 cites·29 claims
- 1166US2024102015A1Antisense Oligonucleotides Targeting SARS-CoV-2UNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1260US2021030781A1Agents and methods for treating pancreatic ductal adenocarcinomasMASSACHUSETTS GEN HOSPITAL·Filed 2020·Application pending·0 cites
- 1354US10588920B2Agents and methods for treating pancreatic ductal adenocarcinomasMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Mar 17, 2020·0 cites·11 claims
- 1452US2022195428A1Oligonucleotides and methods for the treatment of age-related macular degenerationTHE GENERA HOSPITAL CORP·Filed 2020·Application pending·0 cites
- 1552US2018119148A1Regulation of mir-33 micrornas in the treatment of cholesterol-related disordersMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 1649US2017233730A1Regulation of mir-33 micrornas in the treatment of cholesterol-related disordersMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
- 1748US8859519B2Methods targeting miR-33 microRNAs for regulating lipid metabolismNAAR ANDERS M·Filed 2011·Granted Oct 14, 2014·0 cites·16 claims
- 1848US2016186171A1Agents and methods for inhibiting mir-148a for the modulation of cholesterol levelsGEN HOSPITAL CORP·Filed 2014·Application pending·0 cites
- 1945US2012053229A1Regulation of MIR-33 MicroRNAs in the Treatment of Cholesterol-Related DisordersNAAR ANDERS M·Filed 2010·Application pending·0 cites
- 2032US11136291B2Antifungal compounds and uses thereofDANA FARBER CANCER INST INC·Filed 2017·Granted Oct 5, 2021·0 cites·39 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →